This was a post hoc analysis of a previously described 2-year , multicenter , open-label , randomized , outpatient , controlled clinical trial in 172 prepubertal short children [ age 75 24 years ; height standard deviation score ( HSDS ) -264 061 ] classified by baseline peak GH levels as GHD ( < 7 ng/ml ) or ISS ( 7 ng/ml ) .